Literature DB >> 18204804

Prolonged refractory status epilepticus with early and persistent restricted hippocampal signal MRI abnormality.

Laurent Chevret1, Beatrice Husson, Seraphin Nguefack, Astrid Nehlig, Viviane Bouilleret.   

Abstract

We report a series of four children with a prolonged refractory status epilepticus with an early persistent and restricted hippocampal signal MRI abnormality but otherwise no proven etiology. The mean duration of status epilepticus was 53 days (range, 20-91 days) with a mean length of stay in Pediatric Intensive Care Unit (PICU) of 2 months (range, 26-115 days). Neurological outcome showed epilepsy disease in all, and mild to severe disability. In long-term follow-up, the initial MRI signal abnormality developed into a cortical atrophy in all cases. The establishment of the diagnosis, etiology, and options for treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204804     DOI: 10.1007/s00415-008-0713-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Plasmapheresis in Rasmussen's encephalitis. 1996.

Authors:  P I Andrews; M A Dichter; S F Berkovic; M R Newton; J O McNamara
Journal:  Neurology       Date:  2001-12       Impact factor: 9.910

2.  An MRI and neuropathological study of a case of fatal status epilepticus.

Authors:  J Nixon; D Bateman; T Moss
Journal:  Seizure       Date:  2001-12       Impact factor: 3.184

Review 3.  The use of topiramate in refractory status epilepticus.

Authors:  A R Towne; L K Garnett; E J Waterhouse; L D Morton; R J DeLorenzo
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

4.  Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions.

Authors:  K E VanLandingham; E R Heinz; J E Cavazos; D V Lewis
Journal:  Ann Neurol       Date:  1998-04       Impact factor: 10.422

5.  Magnetic resonance imaging follow-up of progressive hippocampal changes in a mouse model of mesial temporal lobe epilepsy.

Authors:  V Bouilleret; A Nehlig; C Marescaux; I J Namer
Journal:  Epilepsia       Date:  2000-06       Impact factor: 5.864

6.  The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity.

Authors:  E P V Wilder-Smith; E C H Lim; H L Teoh; V K Sharma; J J H Tan; B P L Chan; B K C Ong
Journal:  Ann Acad Med Singap       Date:  2005-08       Impact factor: 2.473

Review 7.  Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy.

Authors:  Raymond Voltz
Journal:  Lancet Neurol       Date:  2002-09       Impact factor: 44.182

8.  Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status.

Authors:  Peter Baxter; Antonia Clarke; Helen Cross; Brian Harding; Elaine Hicks; John Livingston; Robert Surtees
Journal:  Seizure       Date:  2003-09       Impact factor: 3.184

9.  The hippocampus in status epilepticus: demonstration of signal intensity and morphologic changes with sequential fast spin-echo MR imaging.

Authors:  R D Tien; G J Felsberg
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

Review 10.  New pharmacotherapy for epilepsy.

Authors:  Asla Pitkanen
Journal:  IDrugs       Date:  2004-05
View more
  6 in total

1.  Less common etiologies of status epilepticus.

Authors:  Thomas P Bleck
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

2.  LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRI.

Authors:  Yu Jia; Huifang Wang; Mengyao Zhang; Min Wei; Zhaoyang Huang; Jing Ye; Aihua Liu; Yuping Wang
Journal:  Acta Neurol Belg       Date:  2022-05-08       Impact factor: 2.396

3.  Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy.

Authors:  Takahiro Iizuka; Naomi Kanazawa; Juntaro Kaneko; Naomi Tominaga; Yutaka Nonoda; Atsuko Hara; Yuya Onozawa; Hiroki Asari; Takashi Hata; Junya Kaneko; Kenji Yoshida; Yoshihiro Sugiura; Yoshikazu Ugawa; Masashi Watanabe; Hitomi Tomita; Arifumi Kosakai; Atsushi Kaneko; Daisuke Ishima; Eiji Kitamura; Kazutoshi Nishiyama
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-09-25

Review 4.  Application of ketogenic diets for pediatric neurocritical care.

Authors:  Kuang-Lin Lin; Jann-Jim Lin; Huei-Shyong Wang
Journal:  Biomed J       Date:  2020-07-05       Impact factor: 4.910

5.  Clinically based score predicting cryptogenic NORSE at the early stage of status epilepticus.

Authors:  Atsuko Yanagida; Naomi Kanazawa; Juntaro Kaneko; Atsushi Kaneko; Ryoko Iwase; Hiroki Suga; Yutaka Nonoda; Yuya Onozawa; Eiji Kitamura; Kazutoshi Nishiyama; Takahiro Iizuka
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-07-29

Review 6.  A clinical approach to diagnosis of autoimmune encephalitis.

Authors:  Francesc Graus; Maarten J Titulaer; Ramani Balu; Susanne Benseler; Christian G Bien; Tania Cellucci; Irene Cortese; Russell C Dale; Jeffrey M Gelfand; Michael Geschwind; Carol A Glaser; Jerome Honnorat; Romana Höftberger; Takahiro Iizuka; Sarosh R Irani; Eric Lancaster; Frank Leypoldt; Harald Prüss; Alexander Rae-Grant; Markus Reindl; Myrna R Rosenfeld; Kevin Rostásy; Albert Saiz; Arun Venkatesan; Angela Vincent; Klaus-Peter Wandinger; Patrick Waters; Josep Dalmau
Journal:  Lancet Neurol       Date:  2016-02-20       Impact factor: 44.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.